Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea. Results From the BACH (Biomarkers in Acute Heart Failure) Trial

Journal of the American College of Cardiology

Volumn 55, Issue 19, 2010, Pages 2062-2076

  Maisel, Alan ^a,e   Mueller, Christian ^b   Nowak, Richard ^c   Peacock, W Frank ^d   Landsberg, Judd W ^e   Ponikowski, Piotr ^f   Mockel, Martin ^g   Hogan, Christopher ^h   Wu, Alan H B ⁱ   Richards, Mark ^j   Clopton, Paul ^a   Filippatos, Gerasimos S ^k   Di Somma, Salvatore ^l   Anand, Inder ^m   Ng, Leong ⁿ   Daniels, Lori B ^e   Neath, Sean Xavier ^e   Christenson, Robert ^o   Potocki, Mihael ^b   McCord, James ^c   Terracciano, Garret ^p   Kremastinos, Dimitrios ^k   Hartmann, Oliver ^q   von Haehling, Stephan ⁱ   Bergmann, Andreas ^q   Morgenthaler, Nils G ^q   Anker, Stefan D ^g,r   more..

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF OTAGO   (New Zealand)

^k NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m VA Minneapolis ^*  (United States)

ⁿ UNIVERSITY OF LEICESTER   (United Kingdom)

^o UNIVERSITY OF MARYLAND   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q Research Department   (Germany)

^r IRCCS SAN RAFFAELE PISANA   (Italy)

more..

Author keywords

acute dyspnea; BACH; markers; pro hormone

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HORMONE PRECURSOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID; WARFARIN;

ACUTE DISEASE; ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DYSPNEA; EDEMA; FEMALE; HOSPITAL READMISSION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REFERENCE VALUE; SURVIVAL RATE; SURVIVAL TIME;

ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 77951646726     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.02.025     Document Type: Article

References (30)

1. Wuerz R.C., and Meador S.A. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med 21 (1992) 669-674
2. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
3. Maisel A.S., Peacock W.F., McMullin N., et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 52 (2008) 534-540
4. Farmakis D., Filippatos G., Tubaro M., et al. Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. Congest Heart Fail 14 Suppl 1 (2008) 25-29
5. Jougasaki M., and Burnett Jr. J.C. Adrenomedullin: potential in physiology and pathophysiology. Life Sci 66 (2000) 855-872
6. Jougasaki M., Rodeheffer R.J., Redfield M.M., et al. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 97 (1996) 2370-2376
7. Jougasaki M., Wei C.M., McKinley L.J., and Burnett J.C. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92 (1995) 286-289
8. Nishikimi T., Saito Y., Kitamura K.I., et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 26 (1995) 1424-1431
9. Struck J., Tao C., Morgenthaler N.G., and Bergmann A. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 25 (2004) 1369-1372
10. Morgenthaler N.G., Struck J., Alonso C., and Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51 (2005) 1823-1829
11. Morgenthaler N.G., Struck J., Thomas B., and Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic Peptide in human plasma. Clin Chem 50 (2004) 234-236
12. Caruhel P., Mazier C., Kunde J., Morgenthaler N.G., and Darbouret B. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clin Biochem 42 (2009) 725-728
13. Leroy O., Santre C., Beuscart C., et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intens Care Med 21 (1995) 24-31
14. Fine M.J., Smith D.N., and Singer D.E. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 89 (1990) 713-721
15. Khan S.Q., Dhillon O., Kelly D., et al. Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 51 (2008) 1857-1864
16. Khan S.Q., O'Brien R.J., Struck J., et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49 (2007) 1525-1532
17. von Haehling S., Jankowska E.A., Morgenthaler N.G., et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol 50 (2007) 1973-1980
18. Gegenhuber A., Struck J., Poelz W., et al. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin Chem 52 (2006) 827-831
19. Gegenhuber A., Struck J., Dieplinger B., et al. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 13 (2007) 42-49
20. DeLong E.R., DeLong D.M., and Coarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
21. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
22. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation 106 (2002) 416
23. McCord J., Mundy B.J., Hudson M.P., et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 164 (2004) 2247-2252
24. Möckel M., Müller R., Vollert J.O., et al. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin Chem 51 (2005) 1624-1631
25. Peacock W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 358 (2008) 2117-2126
26. Dickstein K., Cohen-Solal A., Filippatos G., et al., European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 10 (2008) 933-989
27. Nieminen M.S., Böhm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure on the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
28. ACC/AHA collaborate on guidelines for the evaluation and management of heart failure. Am Fam Physician 53 (1996) 2196-2198
29. Maisel A., Mueller C., Adams Jr. K., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10 (2008) 824-839
30. Ala-Kopsala M., Magga J., Peuhkurinen K., et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588